• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM, NA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM, NA Back to Search Results
Catalog Number 106015
Device Problem Partial Blockage (1065)
Patient Problems Hemolysis (1886); Thrombus (2101)
Event Date 12/26/2017
Event Type  Injury  
Manufacturer Narrative
The initial submission of this event was reported by the manufacturer under mfr.Report # 2916596-2018-00299.This report is being submitted as additional information.4 years and 5 months (age of device) the report of thrombus and elevated ldh could not be confirmed through this evaluation.The account reported that the patient was admitted with elevated ldh.A ramp echocardiogram revealed that the pump was not unloading properly.The patient underwent a pump exchange on (b)(6) 2018 and it was reported that thrombus was visualized on the inlet bearing.Multiple attempts for product return were sent to customer and the pump was not returned to abbott for analysis.The heartmate ii lvas ifu lists device thrombosis and hemolysis as adverse events that may be associated with the use of the heartmate ii left ventricular assist system.This document also describes how pump performance is sensitive to changes in systemic vascular resistance and left ventricular filling.This document additionally provides information regarding anticoagulation therapy and the recommended inr range and outlines indications of pump thrombosis, as well as how to respond to such events.A review of the device history records revealed the device met applicable specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Event Description
The patient was implanted with a left ventricular assist device on (b)(6) 2013.It was reported that the patient was admitted to the hospital for elevated lactate dehydrogenase (ldh).A ramp echocardiogram revealed that the pump was not unloading properly.The patient underwent a pump exchange on (b)(6) 2018.Thrombosis was confirmed in the operating room on the inlet bearing.No additional information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM, NA
Type of Device
LEFT VENTRICULAR ASSIST SYSTEM
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 95488
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 95488
MDR Report Key7712595
MDR Text Key114798765
Report Number2916596-2018-02711
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public00813024011224
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date03/31/2016
Device Catalogue Number106015
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/29/2018
Initial Date FDA Received07/23/2018
Supplement Dates Manufacturer Received01/16/2019
Supplement Dates FDA Received01/23/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/22/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age44 YR
Patient Weight99
-
-